Somatostatin receptor scintigraphy in the management of cerebral malignant ectomesenchymoma: a case report

2001 | journal article. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Somatostatin receptor scintigraphy in the management of cerebral malignant ectomesenchymoma: a case report​
Papos, M.; Pekrun, A.; Herms, J. W.; Behr, T. M.; Meller, J.; Rustenbeck, H. H. & Kretzschmar, H. A. et al.​ (2001) 
Pediatric Radiology31(3) pp. 169​-172​.​ DOI: https://doi.org/10.1007/s002470000404 

Documents & Media

License

GRO License GRO License

Details

Authors
Papos, M.; Pekrun, Arnulf; Herms, J. W.; Behr, T. M.; Meller, J.; Rustenbeck, Hans Heino; Kretzschmar, Hans A.; Becker, W.
Abstract
A 10-year-old girl presented with a cerebral malignant ectomesenchymoma (MEM), a very unusual tumour with undifferentiated mesenchymal as well as ectodermal elements. Somatostatin receptor scintigraphy (SRS) was performed during the diagnostic workup. The recurrent residual tumour mass was exactly visualized with SRS, and was negative after successful treatment of the patient. The potential application of SRS in initial staging, follow-up and therapy planning in MEM is discussed. This is the first application of SRS in MEM.
Issue Date
2001
Status
published
Publisher
Springer
Journal
Pediatric Radiology 
ISSN
0301-0449

Reference

Citations


Social Media